1.46
price down icon4.58%   -0.07
pre-market  Pre-market:  1.53   0.07   +4.79%
loading

Rani Therapeutics Holdings Inc Stock (RANI) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
4.47%
14.03
13.43 17.86 18.29 16.52
Interest Income/Expense
0.15%
1.294
1.296 1.316 1.266 1.207
Depreciation and Amortization
9.25%
0.248
0.227 0.218 0.189 0.188
Operating Income/Loss
4.47%
-14.03
-13.43 -17.86 -18.29 -16.52
Income/Loss From Continuing Operations Before Tax
5.15%
-14.78
-14.05 -18.33 -18.66 -16.83
Income/Loss From Continuing Operations After Tax
5.15%
-14.78
-14.05 -18.33 -18.66 -16.83
Net Income/Loss
5.15%
-14.78
-14.05 -18.33 -18.66 -16.83
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
4.87%
-7.296
-6.957 -9.135 -9.361 -8.46
Basic Average Shares
202.68%
26.03
-25.35 25.55 25.34 25.24
Diluted Average Shares
202.68%
26.03
-25.35 25.55 25.34 25.24
Basic Earnings Per Share
87.87%
-0.29
-2.39 0.36 0.37 0.33
Diluted Earnings Per Share
87.87%
-0.29
-2.39 0.36 0.37 0.33
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$75.07
price up icon 1.39%
$305.39
price down icon 0.55%
$19.19
price down icon 3.62%
$32.68
price down icon 0.52%
$97.47
price down icon 2.84%
biotechnology ONC
$254.57
price up icon 1.89%
Cap:     |  Volume (24h):